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Abstract.  The ERD2 gene, which encodes the yeast 
HDEL (His-Asp-Glu-Leu) receptor, is essential for 
growth (Semenza, J.  C.,  K. G. Hardwick, N.  Dean, 
and H. R. B. Pelham.  1990. Cell.  61:1349-1357; Lewis, 
M. J., D. J.  Sweet, and H. R. B.  Pelham.  1990.  Cell. 
61:1359-1363). SED5, when present in multiple copies, 
enables cells to grow in the absence of Erd2p. Sequence 
analysis of SED5 reveals no significant homology with 
ERD2 or other known genes.  We have raised antibod- 
ies to Sed5p which specifically recognize a  39-kD in- 
tegral membrane protein.  A  stretch of hydrophobic 
residues at the COOH terminus  is predicted to hold 
Sed5p on the cytoplasmic face of intracellular  mem- 
branes. 
Cells that are depleted of Sed5p are unable to trans- 
port carboxypeptidase Y to the Golgi complex, and 
stop growing after a dramatic accumulation of ER 
membranes and vesicles. We conclude that the SED5 
gene is essential for growth and that Sed5p is required 
for ER to Golgi transport. When Sed5p is overexpressed 
the efficiency of ER to Golgi transport is reduced, 
vesicles accumulate, and cellular morphology is per- 
turbed.  Immunofluorescence studies reveal that the 
bulk of Sed5p is not found on ER membranes but on 
punctate structures throughout the cytoplasm, the 
number of which increases upon SED5 overexpression. 
We suggest that Sed5p has an essential role in vesicu- 
lar transport between ER and Golgi compartments and 
that it may itself cycle between these organelles. 
T 
rtE secretory pathway of eukaryotic cells consists  of 
a number of distinct compartments and the transfer of 
proteins from one to another is thought to be mediated 
by transport vesicles (Palade,  1975). Genetic and biochemi- 
cal analyses have identified many of the molecular compo- 
nents involved in the budding,  transfer, targeting,  and fusion 
of forward  transport  vesicles (Rothman  and  Orci,  1992). 
These  steps  are likely  to involve complex molecular ma- 
chines: numerous genetic interactions have been documented 
and a number of multicomponent protein complexes have 
been identified. 
We are interested in the early stages of the secretory path- 
way, particularly the transfer and sorting of proteins between 
the ER and the Golgi complex. Genetic studies have already 
identified around 20 genes whose products are required for 
transport from the ER to the Golgi (Novick et al.,  1980; 
Newman  and  Forro-Novick,  1987; Segev  et  al.,  1988; 
Nakano et al., 1989; Nakano and Muramatsu, 1989; Stearns 
et al., 1990; Nakajima et al., 1991; Ossig et al., 1991; Shim 
et al.,  1991), some of which have been assigned to specific 
steps (Kaiser and Schekman,  1990; Rexach and Schekman, 
1991). For example,  SEC12 and SAR/have been suggested 
to interact directly in the formation of ER-derived transport 
vesicles (d'Enfert et al., 1991) and SEC17 and SEC18 appear 
to form part of a complex involved in the attachment or fu- 
sion of such vesicles with Golgi acceptor membranes (Wil- 
son et al.,  1992). 
Upon reaching the Golgi complex certain proteins are di- 
verted from the "bulk flow" secretory pathway and are recy- 
cled back to the ER (Pelham,  1988, 1989; Dean and Pelham, 
1990).  Such sorting  allows soluble ER proteins that  enter 
transport vesicles to be retrieved  from later compartments. 
A COOH-terminal sorting  signal, usually KDEL (Lys-Asp- 
Glu-Leu) in mammalian  cells or HDEL (His-Asp-Glu-Leu) 
in S.  cerevisiae,  has been shown to be necessary and suf- 
ficient for such retrieval (Munro and Pelham, 1987; Pelham 
et al.,  1988). To date only two membrane proteins,  Sec20p 
and Sed4p,  with such a signal have been described (Sweet 
and  Pelham,  1992;  Hardwick et al.,  1992).  However,  it 
seems likely that other membrane components,  such as those 
of the ER-Golgi transport vesicles, will also be recycled. 
The ERD2 gene encodes the HDEL receptor and is nor- 
malty essential  for growth (Semenza et al.,  1990). We have 
carried out a screen for multicopy suppressor genes (SED 
genes, suppressors of the erd2-deletion)  that can allow cells 
to grow in the absence of Erd2p. We have found that SED1, 
SED2 (SEC12), SED3 (DPM1), and SED4 all encode mem- 
brane proteins,  some of which have essential roles within the 
secretory pathway (Hardwick et al., 1992). In this report we 
present the sequence of SED5 and a functional analysis of its 
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tegral membrane protein that is required for ER-Golgi trans- 
port. We describe defects apparent in cells expressing abnor- 
mal  levels  of Sed5p,  and  suggest  possible  roles  for this 
protein within the secretory pathway. 
Materials and Methods 
Plasmids 
Derivatives of  the original SED5 library isolate (pSEDS) were made by sub- 
cloning fragments into the multicopy expression vector ZUC13. Fragments 
were also subcloned into Bluescript (Promega Biotec, Madison, WI) for 
construction of deletion series and sequencing. Deletion series were made 
with Exonuclease III and Exonuclease VII (Yanisch-Perron et al.,  1985). 
The SED5 gene disruption construct (pS5KO) was made by replacing the 
internal Mscl-Ncol fragment with XhoI-BamHI fragment containing the 
LEU2  marker,  which removes nucleotides 236-833  of the SED5  gene. 
EcoRI and BamHI sites were introduced at the 5' and 3' ends of SED5, 
respectively, via polymerase chain  reaction (PCR) ~ mediated,  oligonu- 
cleotide-directed mutagenesis (Higuchi, 1989).  PCR products were cloned 
into a derivative of the integration vector YIP56X (Pelham et al.,  1988) 
under the control of the GAL/promoter to produce pGALI-SED5 and into 
a derivative of the multicopy  expression plasmid lxlS209  (Semenza et at., 
1990), under the control of the triose phosphate isomerase (TPI) promoter 
to produce pTPI-SEDS.  Myc-tagged MN11 (kindly provided by  Rowan 
Chapman,  LMB)  was cloned as a  XhoI-XbaI fragment into a  YIP56X 
derivative under the control of the TPI promoter. 
Yeast Strains 
Saccharomyces  cerevisiae  strain  JCB102  (MATa  ade2  ade3  his3-A200 
leu2-3, 412 ura3-52 TRP1 erd2A; pLE264 [Kluyveromyces lactis ERD2 ex- 
pressed from the TPI promoter, CEN6, URA3, ADE3]) (kindly provided by 
John Boothroyd) was used for the isolation of the SED5 gene, from a multi- 
copy library lacking the ERD2 gene (Hardwick et al., 1992).  Overexpres- 
sion of SED5 was carried out in SEY6210 (MATot; his3-A200; leu2-3, -112; 
ura3-52; trpl-A901; lys2-801; suc2-A9) (kindly provided by S. Emr, Univer- 
sity of California, San Diego, CA). For the depletion of Sed5p, a strain was 
constructed by first disrupting one copy of SED5 using pS5KO (cut with 
XbaI) in a  SEY6210/CH1305  diploid (CH1305  was  kindly provided by 
Connie Holm, Harvard University, Cambridge, MA). Leu  + transformants 
were then transformed with pGALI-SED5 linearized with XhoI to integrate 
the construct at the URA3 locus. Transformants were then sporulated and 
ura  +,  leu  +  haploid  progeny  were  isolated,  after  tetrad  dissection,  on 
galactose-containing plates. 
Yeast cultures were grown in rich medium containing 1% Bacto yeast ex- 
tract, 2% Bacto peptone (Difco Laboratories Inc., Detroit, MI), and 2 % 
glucose, or in minimal medium containing 0.7 % yeast nitrogen base without 
amino acids (Difco Laboratories Inc.), 2 % glucose, and supplements as de- 
scribed by Sherman et at, (1974). 4% galactose and 0.1% sucrose were used 
as carbon source for expression from pGALI-SED5. Yeast transformations 
were carried out as described by Ito et al. (1983).  Tetrads were dissected 
using a Singer MSM System (Singer Instrument Co. Ltd., Somerset, UK). 
A n tibody Production 
Nucleotides 1-958 of SED5 were amplified by PCR, thereby omitting the 
coding region for the hydrophobic COOH terminus of Sed5p, and inserted 
as a  BamHI-EcoRI  fragment into pGEX-2T  (kindly provided by Ross 
Camidge,  LMB),  producing  an  inframe  fusion  with  glutathione-S- 
transferase (GST). For production of GST-Sed5 fusion protein E. coli con- 
raining this construct were grown overnight; diluted 1:10 in fresh medium 
and grown for 1 h at 37~  i sopropyl ~-l:~-thiogalactopyranoside  was added 
to 0.1 mM and cells incubated for a further 4 h. Cells were spun down at 
5,000 g  for 10 rain and resuspended in ice-cold PBS. Triton X-100 was 
added to 1% and the ceils lysed by sonication. Insoluble material was re- 
moved by centrifugation, glutathione-agarose beads added to the superna- 
rant, and mixed at room temperature for 5 rain. The beads were collected 
by centrifugation and washed three times with ice cold PBS before eluting 
1. Abbreviations used in this paper: CPY, carboxypeptidase Y; PCR, poly- 
merase chain reaction; TPI,  triose phosphate isomerase. 
the fusion protein with 5 mM reduced glutathione in 50 mM Tris (pH 8.0). 
The elution was repeated three times and supernatants pooled before dialyz- 
ing against PBS. The yield of GST-Sed5 fusion protein was "~3 mg/liter. 
Rabbits were injected with an emulsion of Freund's complete adjuvant and 
fusion protein and boosted at 6-wk intervals in incomplete adjuvant ("~0.5 
nag  of fusion protein  was  used  per  injection).  Antiserum  was  affinity 
purified by first removing nonspecilic antibodies by passing the serum twice 
over a 2-ml Affi-Get column to which GST had been coupled, and then 
binding specific antibodies to a similar column to which GST-Sed5  fusion 
protein had been coupled, following manufacturer's instructions (Bio-Rad 
Laboratories, Richmond, CA). The column was washed with 0.5 M NaCI 
in 10 mM Tris, pH 7.5, and specific antibodies eluted with 100 mM glycine, 
pH 2.5. 
Membrane Extractions and Western Blotting 
Membranes were made by glass bead lysis as described by Ossig et al. 
(1991).  Lysis buffer was 200  mM "Iris,  pH  8.0,  6  mM MgCI2,  1 mM 
EGTA, 1 mM DTT, I mM PMSE 1 mM benzamidine, and 3/zg/ml pepsta- 
tin A. Extractions were performed on ice for 30 rain with either: 1 ml of 
lysis buffer, lysis buffer containing 1% Triton X-100,  100 mM NaCI in wa- 
ter, or  100 mM sodium carbonate in water, pH  11.5. Membranes were 
pelleted at 100,000 g in a TLt00.2 in an ultracentrifuge (TL100;  Beckman 
Instruments, Inc., Palo Alto, CA) at 4~  Supernatants were removed, pro- 
teins precipitated in 10% TCA for 30 min, pelleted, washed with ice-cold 
acetone, and resuspended in SDS sample buffer (80 mM Tris, pH 6& 2% 
SDS,  10%  glycerol,  5%  ~-mercaptoethanol, bromphenol blue,  1 mM 
PMSF, 1 mM benzamidine, and 3/~g/ml pepstatin A), as were the mem- 
brane pellets. Whole cell extracts were made from log phase cells: cells 
were spun down, washed in water, resuspended in SDS sample buffer, glass 
beads (Ballotini no. 8) added, samples vortexed at 4*C for 3 rain, and then 
boiled for 2 min. After SDS-PAGE proteins were transferred to nitrocellu- 
lose. Antibody incubations were carded out in 3 % milk in PBS at room tem- 
perature. Anti-CPY serum was diluted to 1/5,000 (kindly provided by Neta 
Dean), affinity-purified anti-Sed5p serum to 1/200, peroxidase-conjugated 
goat anti-rabbit Ig to U4,000 (Sigma Chemical Co, St. Louis, MO). Blots 
were incubated for 1 rain with ECL detection reagents (Amersham Interna- 
tional, Amersham, UK) before autoradiography. 
Immunofluorescence 
10 ml of log phase cells were spun down and fixed with 3.7 % formaldehyde 
in 100 mM potassium phosphate buffer, pH 6.5, for 60-90 min. Cells were 
washed four times with phosphate buffer and once in spheroplasting buffer 
(12 M sorbitol, 100 mM phosphate-citrate, pH 5.9) before resuspending 
in 5 vols of spheroplasting buffer containing 1/10 glusulase and 1/100 1% 
zymolyase 2fir and digesting for 90 min at 30~  Cells were then washed 
with spheroplasting buffer and pipetted on to polylysine-coated microscope 
slides. Slides were plunged into methanol (-20~  for 6 min and acetone 
(-20~  for one rain and air dried before the addition of diluted antiserum. 
Anti-BiP serum (J. Vogel, Princeton University, NJ) was diluted to 1/30,000 
in 3% milk in PBS; 9El0 to U500 (S. Munro, LMB) and afffinity-purified 
anti-Sed5 serum to  t/20,  incubations were carried out overnight at 4~ 
Slides were washed and  incubated in appropriate  secondary antibodies 
(FITC or Texas  red-conjugated sheep anti-mouse Ig or FITC-conjugated 
donkey anti-rabbit Ig [Amersham International] diluted to 1/50) for 1 h at 
room temperature, washed with PBS, and mounted as described by Kilmar- 
tin and Adams (1984).  Images were obtained using an MRC-600 confocal 
laser-scanning microscope (Bio-Rad Laboratories). 
Electron Microscopy 
Yeast cells were fixed with 1.5 % potassium permanganate, sectioned, and 
poststained as described by Sweet and Pelham (1992). 
Results 
We have previously reported the isolation and analysis of 
four SED genes that enable S. cerevisiae to grow in the ab- 
sence of Erd2p (Hardwick et al.,  1992).  Further screening 
for suppressors of the erd2A, using the sectoring assay de- 
scribed previously, yielded a new multicopy suppressor gene 
that we have named SED5. 
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Figure 2. Hydropathy plot of the predicted SED5 product. Hydro- 
phibicity was calculated as in Kyte and Doolittle (1982) using a win- 
dow of t I amino acids. 
the erd2A, confirming that the reading frame that had been 
amplified was the SED5 gene. 
Sequence analysis predicts  that the SED5 gene encodes a 
39-kD protein, with 10 potential N-linked glycosylation sites. 
The hydropathy profile of Sed5p (Fig. 2) reveals a single hy- 
drophobic  stretch,  of sixteen  residues,  at  the  COOH  ter- 
minus of the protein that might be capable of attaching  Sed5p 
to membranes. As there is no signal peptide and the bulk of 
Sed5p is hydrophilic, with over one third of the protein con- 
sisting of serine, threonine, glutamine, and asparagine resi- 
dues,  we suggest that the bulk of Sed5p is cytoplasmic. 
SedSp Is an Integral Membrane Protein 
To allow the above prediction about the membrane attach- 
ment of Sed5p to be tested, we raised polyclonal antibodies 
to a Sed5-GST fusion protein. The bulk of the SED5 reading 
frame, from nucleotides  1-958,  was amplified by PCR and 
cloned into the pGEX-2T vector to produce a GST fusion 
gene.  This construct was used to make a fusion protein in 
E. coli that was purified and injected into rabbits. The serum 
produced was affinity-purified  and used to probe a Western 
blot of two yeast extracts, one of which was made from a 
strain  containing pTPI-SED5  (Fig.  3).  A  39-kD  band  was 
specifically recognized by this serum and was being overex- 
SED5 Is Predicted to Encode a Novel 
Membrane Protein 
The  SED5  library  plasmid  was  restriction  mapped  and 
regions of the insert were subcloned into the multicopy yeast 
expression  vector  ZUC13.  The  suppressing  activity  was 
found to be contained within a 3-kb XbaI fragment.  When 
the NcoI site in this fragment was filled in it no longer sup- 
pressed the erd2A,  indicating that  this restriction site was 
within or near to the SED5 gene.  Overlapping  restriction 
fragments  were cloned  into bluescript and deletion  series 
made and sequenced. This analysis revealed a 1,020-bp read- 
ing frame (Fig.  I) containing the NcoI site at position 833. 
This open reading frame was amplified by PCR and cloned 
into a mutficopy expression vector downstream of the TPI 
promoter. This construct, pTPI-SED5, was able to suppress 
Figure  3.  Immunological  detection of 
Sed5p. Total yeast extracts were immuno- 
blotted with  affinity-purified anti-Sed5p 
serum.  The  wild-type  strain SEY62t0 
(W.Z) was analyzed (lane 1 ), along with 
the  same strain containing  pTPI-SED5 
(lane 2). 
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associated.  Cells  containing 
pTPI-SED5 were lysed by vor- 
texing with glass beads and ex- 
tracted with 1% Triton X-100, 
0.1  M  Na2CO3, pH  11.5, or 
1 M NaC1. After centrifuga- 
tion,  Sed5p was  detected  in 
pellet (P) and supernatant (S) 
fractions  by  immunoblotting 
with  afffinity-purified  anti- 
Sed5p serum. 
pressed in the strain containing pTPI-SED5. One other pro- 
tein, of significantly higher molecular weight,  was  recog- 
nized by the affinity-purified antiserum,  suggesting that it 
may share an epitope with Sed5p. Although Sed5p contains 
ten potential N-linked glycosylation sites none of these ap- 
pear to be used (endoglycosidase H digestion did not result 
in a shift in Sed5p gel mobility [data not shown]), supporting 
the prediction that the bulk of the protein is cytoplasmic. In 
addition, fusion of pro-alpha factor to the COOH terminus 
of Sed5p produced a protein of ~60 kD that was glycosyl- 
ated,  as  determined by  endoglycosidase H  digestion  (not 
shown),  suggesting that  the  COOH  terminus  of Sed5p  is 
membrane-associated and indeed is capable of traversing a 
membrane. 
To  test  the  prediction  that  Sed5p  might  be  tightly  as- 
sociated with membranes  we made glass  bead extracts of 
whole yeast cells and treated them with a range of  buffers be- 
fore spinning at 100,000 g to pellet membrane fractions. The 
results (Fig. 4) indicate that neither a  1 M NaCI buffer nor 
a 0.1 M Na2CO3 buffer, pH  11.5, which would be expected 
to release peripheral membrane proteins, extracted Sed5p 
from membranes whereas 1% Triton X-100 did so efficiently. 
The cross-reacting protein was  extracted from membranes 
with 1 M NaC1 (not shown). Such behavior strongly supports 
the prediction that Sed5p is an integral membrane protein. 
SED5 Is Essential  for Transport between the ER and 
Golgi Compartments 
To analyze the function of SED5 we first constructed a dis- 
ruption plasmid in which coding sequence for 200 residues 
of Sed5p was  deleted  (see Materials  and  Methods).  This 
plasmid  was  used to transform a  diploid yeast strain and 
a  number  of the  resulting  leu  § colonies were  sporulated. 
Tetrad analysis indicated that the SED5 gene is essential for 
growth, as the leu  § haploid progeny containing a disrupted 
sed5 gene were unable to germinate and grow. 
To examine the terminal phenotype of cells depleted of 
Sed5p we made an inducible GALI-SED5 construct and used 
it to transform a diploid strain containing one disrupted copy 
of sed5.  A  number  of the  ura  §  transformants  were  then 
sporulated and leu+/ura  § haploid progeny were selected on 
plates containing galactose. These cells have their sed5 gene 
disrupted with the LEU2 marker and are kept alive by the in- 
ducible GALI-SED5 construct integrated at the URA3 locus. 
Such cells were grown to log phase in galactose medium, 
washed,  and then resuspended in medium containing 2% 
glucose which would repress expression from the GAL/pro- 
moter. At 2-h intervals cell samples were taken and analyzed 
by Western blotting and thin-section EM.  Growth slowed 
Figure 5. Depletion of Sed5p 
leads to the accumulation of 
the ER form of CPY. (A) A 
sed5-disrupted strain contain- 
ingpGALI-SED5 was grown to 
log phase in galactose medi- 
um, then washed and switched 
to medium containing 2 % glu- 
cose.  At the  time  points in- 
dicated cell extracts were made 
and analyzed by immunoblot- 
ting with anti-CPY (upper  panel) and anti-Sed5p (lower  panel) an- 
tibodies. (B) A wild-type strain containing pGALI-SED5 was ana- 
lyzed in a similar manner, after growth in galactose and glucose 
media. Positions of  the pl and mature forms of CPY, and Sed5p are 
indicated. 
after 4 h and stopped 2 h later. Immunoblotting of whole cell 
extracts (Fig.  5 A)  revealed a  gradual depletion of Sed5p 
which was complete after 4 h of  growth in glucose-containing 
medium.  In parallel with this depletion of Sed5p, the ER- 
modified form (pl) of the vacuolar protease carboxypepti- 
dase Y  (CPY) was seen to accumulate. This suggests that 
Sed5p is required for the transport of proteins from the ER 
to the Golgi complex. In  agreement with this,  analysis of 
cells by thin-section EM revealed the gradual accumulation 
of  ER membranes and scattered vesicles within ceils depleted 
of SED5p  (Fig.  6).  After 6  h  of growth in glucose when 
Sed5p was no longer detectable by immunoblotting, large 
clusters of vesicles were observed in many cells. 
The accumulation of ER membranes suggests that Sed5p 
is  important in vesicle budding  from the ER,  but the ac- 
cumulation of clusters of vesicles, most noticeable at later 
time points,  suggests a  role in vesicle targeting or fusion. 
One way to account for both phenotypes would be if Sed5p 
is a component of transport vesicles and has multiple roles 
in budding, targeting, and/or fusion reactions. Alternatively, 
the primary defect in cells depleted of Sed5p may be in vesi- 
cle fusion, and the accumulation of ER membranes could be 
an indirect effect. For example, the accumulation of trans- 
port vesicles could lead to the depletion from the ER of an- 
other recycling protein that is required for vesicle formation 
or budding. Analysis of the time course of Sed5p depletion 
favors the former model as the accumulation of ER mem- 
branes was apparent at early time points and the clusters of 
vesicles were only seen after 6 h  of Sed5p depletion. 
Dominant Effects of the Overexpression  of  SED5 
Multiple  defects  were  observed  when  Sed5p  was  over- 
produced. The strain analyzed in Fig. 5 B contains both a 
wild-type SED5 gene and the integrated GALI-SED5 con- 
struct. In the first lane, where the cells had been grown in 
galactose  medium,  Sed5p  was  being  overexpressed  and 
significantly higher levels of the pl CPY intermediate were 
present, when compared with the second lane where cells 
were grown in glucose and only the wild-type gene was being 
expressed.  We  have  observed a  similar  reduction  in  the 
efficiency of ER  to  Golgi  transport  when SED5  was  ex- 
pressed, either from its own promoter (pSED5) or the TPI 
promoter (pTPI-SED5), on a multicopy vector. 
To determine whether Sed5p has any dominant effects on 
intracellular membrane organization we have analyzed sev- 
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was grown to log phase in galactose medium, then washed and switched to medium containing 2% glucose. At the time points indicated 
cells were fixed with potassium permanganate. Bar, 1 t~m. 
eral strains overexpressing Sed5p by thin-section EM. Cells 
containing pTPI-SED5 contained an increase in the number 
of vesicular structures (Fig. 7 A).  These may be transport 
vesicles of one or more stages of the secretory pathway or 
result from the fragmentation of compartments. No accumu- 
lation of ER membranes was apparent. 
We have previously described membrane defects in cells 
depleted of the HDEL receptor (Semenza et al.,  1990). We 
found that upon depletion of Erd2p, ER to Golgi transport 
continues,  but  that  Golgi-modified precursors  and  mem- 
branes  accumulate.  The  Golgi complex increases  in  size, 
presumably due  to  the  accumulation of ER proteins and 
lipids that are normally recycled. This accumulation appears 
to impair the transport of proteins through the Golgi com- 
plex and eventually halts growth. The Golgi membranes that 
accumulated were not stacked as in sec7cells (Novick et al., 
1981)  and  no accumulation of transport vesicles was  ob- 
served. We have found that overexpression of Sed5p enables 
cells to grow in the absence of Erd2p.  EM analysis of the 
erd2A.pSED5 strain (Fig. 7 B) revealed a dramatic accumu- 
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viously been observed in sec17, sec18, sec20,  and sec22 al- 
leles grown at their permissive temperature (Semenza et al., 
1990).  These strains form the vesicle-accumulating class of 
ER-Golgi sec mutants. It has been  suggested that the ac- 
cumulation  of transport  vesicles  leads  to  a  depletion  of 
Erd2p within the Golgi complex and thereby a reduction in 
the efficiency of HDEL sorting. The accumulation of vesi- 
cles seen upon overexpression of Sed5p supports this hypoth- 
esis, although we can not rule out the possibility that excess 
Sed5p leads to other targeting defects within the cell and the 
fusion  of transport  vesicles  with  inappropriate  compart- 
ments. The slow growth and increase in cell size may reflect 
a reduction in the efficiency  of the targeting of late secretory 
vesicles to the bud. Preliminary experiments suggest that the 
actin cytoskeleton, which is known to be important for the 
targeting of late secretory vesicles, becomes disrupted upon 
Sed5p  overexpression.  However,  other  early sec  mutants 
show similar phenotypes (Sweet,  D., personal communica- 
tion) suggesting that this may be an indirect effect caused by 
other  changes  within the  secretory  pathway,  rather  than 
reflecting a direct interaction between Sed5p and late secre- 
tory vesicles or the cytoskeleton. 
Figure 7. Thin-section  electron micrographs of  cells overexpressing 
SED5. (A) SEY6210, a wild-type strain, containing  pTPI-SED5. (B) 
An erd2-disrupted strain containing pSEDS. Bars, 1 /zm. 
lation of intracellular membranes and vesicles. Such mem- 
branes and vesicles were not observed in most other SED- 
suppressed-erd2A  strains  (Hardwick et al.,  1992),  nor in 
cells depleted of Erd2p,  and we believe that they mainly 
reflect the ability of Sed5p overexpression to lead to mem- 
brane  fragmentation and vesicle  production.  Indeed,  this 
could be the mechanism by which Sed5p allows cells to grow 
without the HDEL receptor. The production of vesicles from 
the Golgi complex would reduce its size and could deplete 
it of ER components interfering with its function. 
A number of other, perhaps indirect, defects were appar- 
ent in cells containing very high levels of Sed5p.  Transfor- 
mants containing pTPI-SED5 grew at slower rates than con- 
trol strains (the doubling time was increased ~threefold), 
and  analysis  of cells  in  the  light microscope  revealed a 
significant increase in cell size (compare Fig. g, A and B). 
We also observed an increase in the level of secretion of the 
luminal ER protein BiP (greater than a twofold increase dur- 
SED5 Is Localized to Punctate Structures Throughout 
the Cytoplasm 
In light of the multiple defects described above we examined 
the intraceUular distribution of Sexi5p. We carried out a num- 
ber of immunofluorescent studies with the affinity-purified 
anti-SedSp  antibodies.  In  wild-type cells  we  observed  a 
small number of brightly staining punctate structures, to- 
gether  with  a  fainter  background  of  punctate  staining 
throughout the cytoplasm (Fig.  8 A).  Upon Sed5p overex- 
pression the cells became larger,  the staining brighter, and 
the number of structures that were labeled increased (Fig.  8 
B).  When the sed5A  strain containing pGALI-SED5  was 
analyzed by immunofluorescence after growth in galactose 
medium,  punctate  structures  were  observed.  When  this 
strain was analyzed after growth in glucose medium, when 
SED5 was not expressed, there was no punctate staining (not 
shown). We conclude that the punctate staining observed in 
wild-type cells and in cells containing pTPI-SED5 is Sed5p. 
To determine the nature of these punctate structures we 
performed double labeling experiments using anti-HDEL 
antibodies to localize the ER, and the mAb 9El0 to localize 
epitope-tagged Mntlp and thereby Golgi membranes. MNT1 
encodes  an  a-l,2-mannosyltransferase (Hausler  and  Rob- 
bins,  1992) which, although Mntlp has not previously been 
localized by immunofluorescence, is thought from biochemi- 
cal and genetic studies to function in a Golgi compartment 
(Franzusoff and  Schekman,  1989;  Hausler  and  Robbins, 
1992).  Fig.  8  C shows the typical ER pattern, of nuclear 
envelope plus a ribbon-like structure at the periphery of the 
cell,  seen  using  anti-BiP  serum.  The  Sed5p-containing 
structures were found throughout the cytoplasm and there- 
fore cannot wholly consist of ER-derived membranes. In fact 
we were unable to detect any significant staining of ER struc- 
tures  with the anti-Sed5p  antibody  (double labeling with 
anti-HDEL mAb, 2E7,  not shown). The staining observed 
for Mntlp, using the 9El0 mAb, did resemble that of Sed5p: 
numerous punctate  structures  were  found throughout the 
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with anti-Sed5p serum;  (B) SEY6210 containing pTPI-SEDS, with anti-Sed5p serum;  (C) SEY6210 with anti-BiP serum;  (D and F) 
SEY-6210 containing pTPI-MNT1 with anti-Sed5p serum; and (E and G) the same cells with 9El0 to detect myc-tagged Mntlp. C-G are 
at twice the magnification of A and B. Brightness levels have been normalized, and therefore should not be compared. Bar, 5 #m. 
cytoplasm (Fig. 8, E and G). However, double labeling re- 
vealed that only a  few of these,  and  in  some cells none, 
colocalized with Sed5p-containing structures (Fig. 8, D-G). 
We conclude that the bulk of Sed5p is not found in the ER, 
and that at least a fraction of it is localized within the Golgi 
complex but that most of it is not in the same compartment 
as Mntlp. These studies would be unable to visualize a low 
level of Sed5p dispersed throughout the ER; a localization 
one might predict if it were a cycling constituent of transport 
vesicles. 
When the  strain  containing pTPI-SED5  was  studied  by 
thin-section EM an accumulation of vesicles was observed 
(Fig. 7 A), and immunoblotting revealed a reduction in the 
efficiency of ER to  Golgi transport.  Our  immunofluores- 
cence studies revealed an increase in the numbers ofpunctate 
structures labeled with anti-Sed5p antibodies in this strain 
(Fig. 8 B) when compared to SEy6210 (Fig. 8 A). We there- 
fore suggest that many of these structures, found throughout 
the cytoplasm, could be ER-Golgi transport vesicles. The 
overexpression of Sed5p may titrate out other proteins re- 
quired for vesicle consumption and thereby lead to the ac- 
cumulation  of transport  vesicles  and  a  reduction  in  the 
efficiency of ER to Golgi transport.  Without further Golgi 
markers we cannot rule out the possibility that Sed5p is also 
found on multiple Golgi compartments, due to the dispersed 
nature of this organelle in S.  cerevisiae  (Franzusoff et al., 
1991). 
Discussion 
We have shown that SED5 encodes a novel integral mem- 
brane  protein  essential  for  ER  to  Golgi  transport.  Im- 
munofluorescence studies revealed that the bulk of Sed5p is 
not  found on  ER  membranes  but  on punctate  structures 
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accumulation of the ER form of CPY along with ER mem- 
branes and clusters of putative transport vesicles. Overex- 
pression of Sed5p leads to a number of defects including a 
reduction in the efficiency of ER to Golgi transport. 
What Is the Function of SedSp? 
At early time points of Sed5p-depletion ER membranes and 
scattered vesicles accumulated,  indicting that there  were 
multiple defects in vesicle budding and targeting/fusion. At 
later time points of Sed5p-depletion clusters of vesicles were 
observed, highlighting the defects in vesicle consumption. It 
is possible that SexiSp is an essential constituent of transport 
vesicles and that it is involved in both vesicle budding and 
targeting/fusion reactions. Depletion of Sed5p would lead to 
defects in vesicle budding and thereby an accumulation of  ER 
membrane. In addition, any vesicles that did bud off from the 
ER  but  that  lacked  Sed5p  would be  defective in  target- 
ing/attachment/fusion reactions  and  would  therefore  ac- 
cumulate.  The bulk of Sed5p  is not found in the ER, as 
judged by immunofluorescence. Therefore, to have a role in 
vesicle budding from the ER, Sed5p must cycle through this 
compartment,  presumably  via  transport  vesicles.  These 
could  be  the  faint punctate  structures  containing Sed5p 
visualized  by  immunofluorescence.  Alternatively,  SedSp 
may be a constituent of Golgi membranes with a role in vesi- 
cle docking or fusion. This could account for the vesicle ac- 
cumulation observed upon depletion of Sed5p. The accumu- 
lation of ER membranes would then be an indirect effect, 
possibly because of the sequestration of another protein, that 
is  required  for  vesicle  budding,  within  the  accumulated 
transport vesicles. Our EM analysis of the time course of 
Sed5p depletion favors the former model as the accumulation 
of ER membranes was apparent at early time points whereas 
the clusters of vesicles were only seen after 6 h of Sed5p 
depletion. 
When Sed5p was overexpressed the efficiency of ER to 
Golgi transport was reduced and an increase in the numbers 
of putative transport vesicles was observed by EM. This cor- 
related  well  with the  increase  in  the  numbers  of Sed5p- 
containing  structures  observed  by  immunofluorescence, 
supporting the model that Sed5p is a constituent of transport 
vesicles. Overexpression of Sed5p may lead to the produc- 
tion of vesicles that, although they do contain Sed5p, do not 
contain other proteins required for their efficient transfer to 
the Golgi complex. Alternatively, if Sed5p is a constituent 
of Golgi membranes, its overexpression may affect the struc- 
ture and function of  this "acceptor" compartment and thereby 
reduce the efficiency of vesicle consumption. 
It is also possible that some of  the vesicles seen to accumu- 
late upon Sed5p depletion are retrograde transport vesicles. 
It is difficult to determine genetically whether Sed5p has a 
role  in  Golgi to  ER  retrograde  transport  because  of its 
significant role in the forward pathway.  However, using the 
anti-Sed5p antibodies we should now be able to determine 
whether Sed5p is enriched within transport vesicle fractions 
or Golgi membranes, and define more precisely its role in 
vesicular transport. 
The ERD2 gene encodes the yeast HDEL receptor and is 
essential for growth (Semenza et al., 1990). When Erd2p is 
depleted in cells their Golgi complex becomes severely dis- 
rupted, both functionally and morphologically. We believe 
that the essential function of Erd2p is to promote retrograde 
transport and thus maintain a balance in the traffic of mem- 
brane constituents to and from the Golgi complex. There are 
two ways that overexpression of Sed5p could enable cells to 
balance Golgi membrane traffic in the absence of Erd2p. One 
would be to reduce the flow of membrane into the Golgi 
complex, by reducing the efficiency of ER to Golgi trans- 
port. The other way would be to stimulate transport from the 
Golgi complex, either back to the ER or to the cell surface. 
Here we have shown that SED5 overexpression leads to a 
reduction in the efficiency  of ER to Golgi transport, and also 
to the production of transport vesicles some of which may 
be Golgi derived. We are at present uncertain which prop- 
erty of Sed5p it is that allows cells to grow without the HDEL 
receptor. 
Although Sed5p is not closely related to any known pro- 
tein,  it shares some features with other proteins that are 
thought to be involved in vesicular transport. Adjacent to the 
COOH-terrninal membrane anchor of Sed5p is a stretch of 
predicted amphipathic helix (residues 252-315)  similar to 
those found in proteins with a coiled-coil motif, carrying a 
net charge of -6. A similar acidic coiled-coil motif, adjacent 
to a COOH-terminal membrane anchor, is found in the yeast 
PEP12 product (K.  Becherer and E.  Jones,  GenBank se- 
quence YSCPEP12P), and in the rat protein syntaxin  (Bennett 
et al.,  1992).  Both of these proteins show ",,33%  sequence 
identity to Sed5p in this region; they are not obviously ho- 
mologous in other regions, although they are quite similar 
in size and each has other stretches of predicted amphipathic 
helix.  Pepl2p  is required for transport of proteins to the 
vacuole; it is found predominantly on the vacuolar mem- 
brane, and possibly also in the Golgi complex (op.  cit. by 
Preston et al.,  1991). Syntaxin has been implicated in the 
targeting of synaptic vesicles to the plasma membrane, and 
is thought to be at least partly located on the plasma mem- 
brane 0~rmett et al.,  1992).  These analogies in structure 
and function suggest that Sed5p may be a member of a family 
of proteins that perform similar roles in vesicular transport, 
perhaps in the targeting step. The overall structure of Sed5p 
is also reminiscent of that of Boslp, Sly2p, and Slyl2p, yeast 
membrane proteins involved in ER-Golgi transport, which 
are themselves similar to the synaptobrevins found on synap- 
tic vesicles (Shim et al.,  1991; Ossig et al.,  1991). 
To date few integral membrane proteins of the secretory 
pathway have been described.  However,  it is clear that a 
number of such proteins are likely to exist with important 
functions in vesicular transport.  For example, an integral 
membrane protein is thought to act as a  receptor for the 
SNAP proteins complexed with NSF protein on the surface 
of uncoated intra-Golgi transport vesicles (Wilson et al., 
1992). In addition, it seems likely that peripheral membrane 
proteins of coated membrane structures, such as the ARF 
and COP proteins (Rothman and Orci,  1992),  will interact 
with integral membrane proteins. Further biochemical anal- 
ysis should indicate whether Sed5p performs one of these, 
or some other essential role in vesicular transport. Analysis 
of further SED genes is in progress and may lead to the 
identification of further novel membrane components of the 
secretory pathway. 
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